University of Leicester proves feasibility of antibody based targeted senolytics
IFL Science - 28-Oct-2021New study results show clinical applications in pathological ageing
Join the club for FREE to access the whole archive and other member benefits.
Associate Professor in Department of Molecular and Cell Biology at University of Leicester.
My research interest is to understand the mechanisms involved in cancer and ageing, in order to design better targeted and personalized therapies. I completed a medical degree at the University of Barcelona, where I also obtained a PhD in Molecular Genetics. After a few years at Mount Sinai Hospital, in New York, I came to the University of Leicester as a New Blood Lecturer in Mechanisms of Cell Death and head of the Mechanisms of Cancer and Ageing Laboratory.
Visit website: http://www.macip.org/
See also: University of Leicester - Public research university for UK and international students
Details last updated 03-Jan-2020
17-Oct-2024
Congress that addresses healthy ageing and medical longevity (Alicante, Spain)
New study results show clinical applications in pathological ageing
nanoMIPs could improve the specificity of senolytics